NQO1 and trisomy 21: Elevated oxidative stress, such as reduced Nuclear Factor Erythroid 2‐Related Factor 2 (NRF2) activity and increased NAD(P)H Quinone Dehydrogenase 1 (NQO1), serves as a novel biomarker for trisomy 21 [13, 24, 45, 51].